JACOBS LEVY EQUITY MANAGEMENT, INC - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445107. A total of 31 filers reported holding KEMPHARM INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of KEMPHARM INC
ValueSharesWeighting
Q1 2019$221,000
+108.5%
132,126
+121.9%
0.00%
+50.0%
Q4 2018$106,000
-41.4%
59,552
+57.8%
0.00%
-33.3%
Q3 2018$181,000
-43.6%
37,736
-23.5%
0.00%
-40.0%
Q2 2018$321,000
-8.3%
49,346
+11.5%
0.01%
-16.7%
Q1 2018$350,000
+59.8%
44,246
-18.0%
0.01%
+50.0%
Q4 2017$219,000
+7.4%
53,988
-2.2%
0.00%0.0%
Q3 2017$204,00055,1880.00%
Other shareholders
KEMPHARM INC shareholders Q4 2017
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,791,631$7,256,0004.21%
Arete Wealth Advisors, LLC 817,822$3,312,0001.08%
NORTHWEST WEALTH MANAGEMENT, LLC 16,070$65,0000.05%
Iowa State Bank 20,171$82,0000.04%
Alyeska Investment Group, L.P. 992,338$4,019,0000.03%
C WorldWide Group Holding A/S 435,528$1,764,0000.03%
MENTA CAPITAL LLC 26,920$109,0000.02%
Evanson Asset Management, LLC 17,094$69,0000.01%
Creative Planning 453,523$1,837,0000.01%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 10,646$43,0000.01%
View complete list of KEMPHARM INC shareholders